Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

394JPY
6:00am GMT
Change (% chg)

¥-15 (-3.67%)
Prev Close
¥409
Open
¥404
Day's High
¥405
Day's Low
¥394
Volume
4,083,400
Avg. Vol
5,165,173
52-wk High
¥652
52-wk Low
¥219

Latest Key Developments (Source: Significant Developments)

Pledpharma and Solasia enter license agreement on Pledox in Asia
Monday, 20 Nov 2017 

Nov 20 (Reuters) - PLEDPHARMA AB (PUBL) :PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA .PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY UPFRONT, DEVELOPMENT, REGULATORY AND SALES MILESTONES OF UP TO ABOUT USD 83 MILLION​.PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY INDUSTRY STANDARD ROYALTY RATES ON SALES​.PLEDPHARMA AB (PUBL) - ‍WILL ALSO FULLY FINANCE AN EXPANSION OF PHASE III PROGRAM FOR PLEDOX​.‍TOTAL VALUE OF UPFRONT AND MILESTONE PAYMENTS IS UP TO JPY 9.3 BILLION​.‍PHASE III STUDIES ANTICIPATED TO BE INITIATED END OF 2017 WITH TOP LINE RESULTS EXPECTED IN 2020​.  Full Article

BRIEF-Pledpharma and Solasia enter license agreement on Pledox in Asia

* PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA